Home » Topics » Cancer, BioWorld Science

Cancer, BioWorld Science
RSS

New antiangiogenic agents under development at Merck KGaA

Aug. 9, 2000

Novel growth factor receptor inhibitors described by Sugen

Aug. 9, 2000

Genasense receives orphan drug status for treatment of malignant melanoma

Aug. 9, 2000

Chemotherapy of head and neck cancer enhanced by gene therapy

Aug. 9, 2000

Tamoxifen plus cisplatin improves survival in melanoma patients

Aug. 9, 2000

HumaRAD pilot clinical results reported for head and neck cancer

Aug. 9, 2000

DNA topoisomerase II inhibitors under study at Lafon

Aug. 8, 2000

New serine protease inhibitors useful for treating cancer

Aug. 8, 2000

PR-000350 shows promise in improving efficacy of radiation therapy

Aug. 8, 2000

Cell Pathways completes phase Ib trial of CP-461

Aug. 7, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Feb. 12, 2025.
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...
News in brief
BioWorld Asia
BioWorld Asia briefs for Feb. 10, 2026
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...